Mometasone Furoate Market Analysis

 Route of administration (Topical, Nasal, Oral)

In mometasone furoate market, topical segment is poised to account for around 42% share by 2036. The reason behind this lucrative growth is impelled by the surge in the growth of skin conditions like eczema, psoriasis, and dermatitis worldwide. According to a report, about 223 million people worldwide, including 43 million children and young adults, suffered from atopic dermatitis in 2022. Mometasone, in the form of creams, ointments, and lotions, has shown great efficacy in managing these conditions, which leads to its popularity among healthcare professionals and patients.

In addition, advancements in formulation technology have improved the delivery and absorption of mometasone through the skin, enhancing its efficacy. Therefore, these innovations have led to the expansion of the topical segment.

Indication (Allergic Rhinitis, Inflammatory Skin Disorders, Asthma)

The allergic rhinitis segment in mometasone furoate market is set to garner a notable share. It is likely to remain the second largest segment, led by the substantial growth in quicker and higher-quality diagnostic techniques. In addition, the enormous financial burden on society due to disability and early death raises costs for prescription drugs, direct health care, and indirect costs associated with lost productivity.

Treatment for allergic asthma is often required in conjunction with perennial allergic rhinitis. The market size expansion for treatments for allergic rhinitis is also being impacted by this illness worldwide. Moreover, mometasone nasal spray is frequently recommended to help reduce allergic rhinitis symptoms. The expansion of this market size can be attributed to mometasone's efficacy in treating allergic rhinitis.

Our in-depth analysis of the global market includes the following segments: